Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07171359 · ClinicalTrials.gov registry record · NA
TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)
A NA study, sponsored by Washington State University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT07171359 is a NA study that is actively recruiting participants, run by Washington State University. The registered enrollment target is 60 participants.
The verdict
NCT07171359, a NA study, is actively recruiting participants, sponsored by Washington State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The study aims to explore the potential of Transcranial Magnetic Stimulation (TMS), particularly Theta Burst Stimulation (TBS), as an adjunctive treatment to enhance recovery outcomes (consumption and craving; withdrawal symptoms; mental, physical, sleep, and cognitive health; engagement with therapy, etc.) in individuals with Opioid Use Disorder (OUD) and individuals with Alcohol Use Disorder (AUD). This project will be completed in partnership with Another Chance Rehab (Portland): Portland's top addiction treatment program offering evidence-based treatment programs for a range of substance use disorders. Another Chance Rehab will serve as the project site for this work.
Interventions
- DEVICE TMS Low-Dose
- DEVICE TMS High-Dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2027-06-01 |
| Est. Completion | 2027-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07171359
The ClinicalTrials.gov registry entry for NCT07171359 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington State University, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TMS Low-Dose is the first listed.
NCT07171359 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07171359 about?
NCT07171359 is a clinical study titled "TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)". The study aims to explore the potential of Transcranial Magnetic Stimulation (TMS), particularly Theta Burst Stimulation (TBS), as an adjunctive treatment to enhance recovery outcomes (consumption and craving; withdrawal symptoms; mental, physical, sleep, and cognitive health; engagement with therap...
What is the current status of trial NCT07171359?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2027-06-01. Estimated completion is 2027-10-01.
What interventions are being tested in trial NCT07171359?
The interventions under investigation include: TMS Low-Dose (DEVICE), TMS High-Dose (DEVICE).
Who is sponsoring clinical trial NCT07171359?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.